Fundz

Who to call at Halozyme Therapeutics, and when

Fundz watches for the moments Halozyme Therapeutics starts buying, and tells you who to reach.

  • An alert the day Halozyme Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Halozyme Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Halozyme Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Halozyme Partners with GSK to Enhance Subcutaneous Delivery of Oncology Drugs

May 10, 2026

Contract Type

agreement

San DiegoManufacturingBiotechnologyHealth CarePharmaceuticalBiopharma

Description

Halozyme Therapeutics has announced a new global collaboration with GSK to utilize its ENHANZE technology for subcutaneous delivery of multiple oncology products. This agreement will develop subcutaneous formulations for antibody drug conjugates and introduce potential royalty streams from GSK’s oncology portfolio.

Company Information

Company

Halozyme Therapeutics

Location

12390 El Camino Real

San Diego, California, United States

About

Halozyme is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. The Company has two commercial proprietary products, Hylenex® and XYOSTED®, partnered commercial products and ongoing product development programs with several pharmaceutical companies.

Related People

Cortney
Likely contact at this company
••••••••@••••••••

See Cortney's verified email →

Vidhyadhar
Senior decision-maker at this company
••••••••@••••••••

See Vidhyadhar's verified email →

Richard
Senior decision-maker at this company
••••••••@••••••••

See Richard's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Halozyme Therapeutics's next move

Learn about Strategic plan

Halozyme Therapeutics signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.